NEW YORK and SANTA BARBARA, Calif., July 30, 2024 (GLOBE NEWSWIRE) -- Phytanix Bio, a pioneering preclinical...
Phytanix Bio is a preclinical stage pharmaceutical company founded by former members and associates of GW Pharmaceuticals, holding exclusive...
Chain Bridge I (the “Company”) (NASDAQ: CBRGU, CBRG, CBRGW), a special purpose acquisition company, today announced that it will redeem all of...
0001845149 false 0001845149 2023-06-13 2023-06-13 0001845149...
Securities and Exchange Commission, Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment...
FORM 4 ☒ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...
FORM 4 ☐ Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b...
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A...
0001845149--12-312022Q3false0.5244000P10D0.500018451492022-01-012022-12-310001845149CBRGU:CommonClassaSubjectToRedemptionMember2023-03-310001845149...
0001845149 false 0001845149 2023-05-10 2023-05-10 0001845149...
0001845149 false 0001845149 2023-04-27 2023-04-27 0001845149...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.